| Satellos Announces Forazapadin as Assigned International Nonproprietary Name for Lead Drug Candidate, SAT-3247 |
Globe Newswire |
09/09 |
07:00 |
| Opus Genetics Announces Positive Low Dose Cohort 1 Data from Phase 1/2 Clinical Trial of OPGx-BEST1 and Successful FDA Type C Meeting with Potential Phase 3 Dosing in 2027 |
Globe Newswire |
09/09 |
07:00 |
| Lightbridge Secures Access to Idaho National Laboratory's Advanced Test Reactor Loop Facility to Irradiate Clad Lightbridge Fuel™ Rodlets Under Prototypic Commercial Reactor Conditions |
Globe Newswire |
09/09 |
07:00 |
| ODDITY Tech Reports Second Quarter 2026 Results, Expects Sequential Revenue Improvement in the Third Quarter |
Globe Newswire |
09/09 |
07:00 |
| Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment |
Globe Newswire |
09/09 |
07:00 |
| Can-Fite: Publication Reports Improvement in Decompensated Cirrhosis with Namodenoson and Successful Bridging to Liver Transplantation |
Globe Newswire |
09/09 |
07:00 |
| SunHydrogen CTO Details Path from Demonstrated Module Performance to Commercialization |
Globe Newswire |
09/09 |
07:00 |
| OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026 |
Globe Newswire |
09/09 |
07:00 |
| Operative Launches Unified Platform to Transform Advertising & Broadcast Management |
Globe Newswire |
09/09 |
07:00 |
| Troilus Reports Updated Technical Report Following Completion of Basic Engineering, Delivering After-Tax US$3.2 Billion NPV5%, 22% IRR, and Cashflow of US$6.9 Billion at Base Case Gold Price of US $3,600/oz |
Globe Newswire |
09/09 |
07:00 |
| LifeStance Health Group Announces Launch of Secondary Public Offering |
Globe Newswire |
09/09 |
07:00 |
| YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs |
Globe Newswire |
09/09 |
06:55 |
| Digital Substations Market Size, Share, Insights, Competitive Intelligence, Demand |
Globe Newswire |
09/09 |
06:53 |
| INV Legal Notice: BFA Law Notifies Innventure Investors that Lost Money of the Imminent October 27 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| CDNL Legal Notice: BFA Law Notifies Cardinal Infrastructure Investors that Lost Money of the Ongoing Securities Fraud Investigation |
Globe Newswire |
09/09 |
06:36 |
| CCB Legal Notice: BFA Law Notifies Coastal Financial Investors that Lost Money of the Ongoing Securities Fraud Investigation |
Globe Newswire |
09/09 |
06:36 |
| GIL Legal Notice: BFA Law Notifies Gildan Investors that Lost Money of the Ongoing Securities Fraud Investigation |
Globe Newswire |
09/09 |
06:36 |
| RXT Legal Notice: BFA Law Notifies Rackspace Technology Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| PLNT Legal Notice: BFA Law Notifies Planet Fitness Investors that Lost Money of the Imminent September 14 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| GDDY Legal Notice: BFA Law Notifies GoDaddy Investors that Lost Money of the Imminent October 26 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| YSS Legal Notice: BFA Law Notifies York Space Systems Investors that Lost Money of the Imminent October 30 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| UWMC Legal Notice: BFA Law Notifies UWM Holdings Investors that Lost Money of the Imminent October 13 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| CAPR Legal Notice: BFA Law Notifies Capricor Therapeutics Investors that Lost Money of the Imminent September 28 Securities Fraud Class Action Deadline |
Globe Newswire |
09/09 |
06:36 |
| MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management |
Globe Newswire |
09/09 |
06:30 |
| Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference |
Globe Newswire |
09/09 |
06:30 |
